All News

Partnerships: An EU project aims to design road-hardened microchips in a fast-changing market.

Imperial College London's technology commercialisation company is betting on a spin-out company, deltaDOT, to speed detection and decrease costs of finding new proteins for drug discovery.

A new life-science fund said it raised €240.3 million – and promptly announced its first two investments.

Avidex is teaming up with diabetes specialists at King’s College London to work on a new approach to treating the Type I form of the disease.

Nemerix, a semiconductor company spun out from the Swiss Federal Institute of Technology in Zurich, has closed a €25 million series B financing round.

Nuala’s Moran’s roundup of news and views in the management of intellectual assets Helpdesk

Oslo-based anticancer company Algeta has closed a series A financing round totaling €23 million.

Michael Kenward's roundup of new studies, reports and tools for the business of science

Take care: not all spin-outs end in fame and glory. The path from academia to industry is strewn with pitfalls…

Mary Lisbeth D'Amico's first fortnightly funding column reveals how coming out on top in a start-up talent show does not guarantee funding.

Scientists love to complicate things; and if you're not in the same field, or – worse – are in business or investment, then it's easy to get lost. Enter the Science|Business Quick Guides to some of the hottest fields of science and technology…

One of Europe’s biggest research organisations, Fraunhofer Gesellschaft in Germany, is pushing to close its first venture fund to finance spin-off companies from the institute.